BIVI logo

BioVie (BIVI) EBITDA

Annual EBITDA

-$29.00 M
+$16.73 M+36.59%

June 30, 2024

Summary

Performance

1-Year Change

+36.59%

3-Year Change

+77.6%

5-Year Change

-1209.37%

15-Year Change

-2533%

BIVI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.5%
BIVI annual EBITDA is higher than 44.5% of companies in Healthcare sector

High & Low

All-time High

-$233.00 K

3-Year Low

-$129.46 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
BIVI previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
BIVI next annual earnings announcement has not yet been scheduled

OtherBIVIprofitabilitymetrics:

Annual Revenue

-
BIVI annual revenue value is unknown

Annual Net Income

-$32.12 M
BIVI annual net profit is -$32.12 million

Annual EBIT

-$29.23 M
BIVI annual earnings before interest & taxes is -$29.23 million

Annual EPS

-$7.30
BIVI annual earnings per share is -$7.30

Quarterly EBITDA

-$3.84 M
+$604.80 K+13.61%

September 30, 2024

Summary

Performance

3-Month Change

+13.61%

1-Year Change

+60.21%

3-Year Change

+60.21%

5-Year Change

+60.21%

BIVI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.39%
BIVI quarterly EBITDA is higher than 52.39% of companies in Healthcare sector

High & Low

All-time High

$7.95 M
BIVI quarterly EBITDA is currently -148.28% below its historical high of $7.95 million

3-Year Low

-$14.58 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIVI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
BIVI next earnings announcement is scheduled for Feb 13, 2025

OtherBIVIprofitabilitymetrics:

Quarterly Revenue

-
BIVI quarterly revenue value is unknown

Quarterly Net Income

-$4.15 M
BIVI quarterly net profit is -$4.15 million

Quarterly EBIT

-$3.90 M
BIVI quarterly earnings before interest & taxes is -$3.90 million

Quarterly EPS

-$0.70
BIVI quarterly earnings per share is -$0.70

TTM EBITDA

-$23.19 M
+$5.81 M+20.04%

September 30, 2024

Summary

Performance

3-Month Change

+20.04%

1-Year Change

+49.67%

3-Year Change

+49.67%

5-Year Change

+49.67%

BIVI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.94%
BIVI TTM EBITDA is higher than 46.94% of companies in Healthcare sector

High & Low

All-time High

$5.58 M
BIVI TTM EBITDA is currently -515.32% below its historical high of $5.58 million

3-Year Low

-$148.06 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BIVI previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
BIVI next earnings announcement is scheduled for Feb 13, 2025

OtherBIVIprofitabilitymetrics:

TTM Revenue

-
BIVI TTM revenue value is unknown

TTM Net Income

-$25.56 M
BIVI TTM net profit is -$25.56 million

TTM EBIT

-$23.42 M
BIVI TTM earnings before interest & taxes is -$23.42 million

TTM EPS

-$5.20
BIVI TTM earnings per share is -$5.20

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$29.00 M
BIVI annual EBITDA is -$29.00 million

Annual Net Income

-$32.12 M
BIVI annual net profit is -$32.12 million

Annual Interest Expense

$2.89 M
BIVI annual interest expense is $2.89 million

Annual Income Tax

-
BIVI annual income tax value is unknown

Annual D&A

$229.40 K
BIVI annual depreciation & amortization is $229.40 thousand

BIVI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.6%+60.2%+49.7%
3 y3 years+77.6%+60.2%+49.7%
5 y5 years-1209.4%+60.2%+49.7%

BIVI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.4%+77.6%at high+73.7%at high+84.3%
5 y5-year-1209.4%+77.6%-148.3%+97.1%-515.3%+84.3%
alltimeall time<-9999.0%+77.6%-148.3%+97.1%-515.3%+84.3%

BioVie EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.84 M(-13.6%)
-$23.19 M(-20.0%)
Jun 2024
-$29.00 M(-36.6%)
-$4.44 M(-39.8%)
-$29.00 M(-10.8%)
Mar 2024
-
-$7.38 M(-1.9%)
-$32.50 M(-16.7%)
Dec 2023
-
-$7.52 M(-22.0%)
-$39.02 M(-15.3%)
Sep 2023
-
-$9.65 M(+21.4%)
-$46.07 M(+0.8%)
Jun 2023
-$45.73 M(+93.0%)
-$7.95 M(-42.8%)
-$45.73 M(+1.9%)
Mar 2023
-
-$13.90 M(-4.6%)
-$44.88 M(+21.2%)
Dec 2022
-
-$14.58 M(+56.7%)
-$37.05 M(+34.7%)
Sep 2022
-
-$9.30 M(+30.9%)
-$27.51 M(+16.1%)
Jun 2022
-$23.69 M(-81.7%)
-$7.10 M(+17.1%)
-$23.69 M(-84.0%)
Mar 2022
-
-$6.06 M(+20.3%)
-$148.06 M(+2.2%)
Dec 2021
-
-$5.04 M(-8.1%)
-$144.93 M(+1.4%)
Sep 2021
-
-$5.48 M(-95.8%)
-$142.89 M(+10.4%)
Jun 2021
-$129.46 M(+1008.9%)
-$131.48 M(+4378.8%)
-$129.46 M(+717.2%)
Mar 2021
-
-$2.94 M(-2.2%)
-$15.84 M(+20.2%)
Dec 2020
-
-$3.00 M(-137.7%)
-$13.18 M(+283.4%)
Sep 2020
-
$7.95 M(-144.5%)
-$3.44 M(-70.6%)
Jun 2020
-$11.68 M(+427.2%)
-$17.86 M(+6383.9%)
-$11.68 M(-309.1%)
Mar 2020
-
-$275.40 K(-104.1%)
$5.58 M(+10.2%)
Dec 2019
-
$6.74 M(-2455.3%)
$5.07 M(-339.2%)
Sep 2019
-
-$286.30 K(-52.2%)
-$2.12 M(-4.3%)
Jun 2019
-$2.21 M
-$598.50 K(-24.3%)
-$2.21 M(+6.3%)
Mar 2019
-
-$790.70 K(+78.4%)
-$2.08 M(+8.1%)
DateAnnualQuarterlyTTM
Dec 2018
-
-$443.20 K(+15.9%)
-$1.93 M(+0.3%)
Sep 2018
-
-$382.30 K(-18.1%)
-$1.92 M(-10.4%)
Jun 2018
-$2.14 M(+94.6%)
-$466.60 K(-26.4%)
-$2.14 M(+3.9%)
Mar 2018
-
-$633.90 K(+44.9%)
-$2.06 M(+33.1%)
Dec 2017
-
-$437.50 K(-27.7%)
-$1.55 M(+9.7%)
Sep 2017
-
-$604.90 K(+56.8%)
-$1.41 M(+28.2%)
Jun 2017
-$1.10 M(+189.2%)
-$385.70 K(+218.2%)
-$1.10 M(+17.9%)
Mar 2017
-
-$121.20 K(-59.7%)
-$934.30 K(+7.4%)
Dec 2016
-
-$300.50 K(+2.2%)
-$869.80 K(+40.9%)
Sep 2016
-
-$294.00 K(+34.5%)
-$617.30 K(+64.2%)
Jun 2016
-$380.80 K(+63.4%)
-$218.60 K(+285.5%)
-$376.00 K(+77.2%)
Mar 2016
-
-$56.70 K(+18.1%)
-$212.20 K(+3.8%)
Dec 2015
-
-$48.00 K(-8.9%)
-$204.50 K(-10.0%)
Sep 2015
-
-$52.70 K(-3.8%)
-$227.10 K(-2.6%)
Jun 2015
-$233.00 K(-27.6%)
-$54.80 K(+11.8%)
-$233.20 K(-33.7%)
Mar 2015
-
-$49.00 K(-30.6%)
-$351.60 K(+0.3%)
Dec 2014
-
-$70.60 K(+20.1%)
-$350.60 K(+7.2%)
Sep 2014
-
-$58.80 K(-66.1%)
-$327.10 K(+1.6%)
Jun 2014
-$321.90 K
-$173.20 K(+260.8%)
-$321.80 K(+93.7%)
Mar 2014
-
-$48.00 K(+1.9%)
-$166.10 K(+40.6%)
Dec 2013
-
-$47.10 K(-12.0%)
-$118.10 K(+66.3%)
Sep 2013
-
-$53.50 K(+205.7%)
-$71.00 K(+305.7%)
Jun 2013
-
-$17.50 K
-$17.50 K

FAQ

  • What is BioVie annual EBITDA?
  • What is the all time high annual EBITDA for BioVie?
  • What is BioVie annual EBITDA year-on-year change?
  • What is BioVie quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BioVie?
  • What is BioVie quarterly EBITDA year-on-year change?
  • What is BioVie TTM EBITDA?
  • What is the all time high TTM EBITDA for BioVie?
  • What is BioVie TTM EBITDA year-on-year change?

What is BioVie annual EBITDA?

The current annual EBITDA of BIVI is -$29.00 M

What is the all time high annual EBITDA for BioVie?

BioVie all-time high annual EBITDA is -$233.00 K

What is BioVie annual EBITDA year-on-year change?

Over the past year, BIVI annual EBITDA has changed by +$16.73 M (+36.59%)

What is BioVie quarterly EBITDA?

The current quarterly EBITDA of BIVI is -$3.84 M

What is the all time high quarterly EBITDA for BioVie?

BioVie all-time high quarterly EBITDA is $7.95 M

What is BioVie quarterly EBITDA year-on-year change?

Over the past year, BIVI quarterly EBITDA has changed by +$5.81 M (+60.21%)

What is BioVie TTM EBITDA?

The current TTM EBITDA of BIVI is -$23.19 M

What is the all time high TTM EBITDA for BioVie?

BioVie all-time high TTM EBITDA is $5.58 M

What is BioVie TTM EBITDA year-on-year change?

Over the past year, BIVI TTM EBITDA has changed by +$22.89 M (+49.67%)